Total Payments
$380,099
2024 Payments
$81,924
Companies
45
Transactions
1,593
Medicare Patients
6,470
Medicare Billing
$3.0M
Payment Breakdown by Category
Other$305,398 (80.3%)
Food & Beverage$32,195 (8.5%)
Travel$31,053 (8.2%)
Consulting$11,125 (2.9%)
Education$328.52 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $283,160 | 113 | 74.5% |
| Food and Beverage | $32,195 | 1,354 | 8.5% |
| Travel and Lodging | $31,053 | 100 | 8.2% |
| Honoraria | $22,238 | 12 | 5.9% |
| Consulting Fee | $11,125 | 4 | 2.9% |
| Education | $328.52 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $198,727 | 248 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $88,585 | 108 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $39,372 | 54 | $0 (2024) |
| Horizon Therapeutics plc | $25,383 | 57 | $0 (2023) |
| Amgen Inc. | $9,884 | 182 | $0 (2024) |
| ABBVIE INC. | $5,295 | 204 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,846 | 99 | $0 (2024) |
| PFIZER INC. | $1,655 | 125 | $0 (2024) |
| UCB, Inc. | $1,589 | 89 | $0 (2024) |
| Janssen Biotech, Inc. | $1,428 | 69 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $81,924 | 253 | GlaxoSmithKline, LLC. ($35,882) |
| 2023 | $91,566 | 275 | GlaxoSmithKline, LLC. ($30,962) |
| 2022 | $97,550 | 255 | GlaxoSmithKline, LLC. ($47,273) |
| 2021 | $58,126 | 162 | GlaxoSmithKline, LLC. ($43,836) |
| 2020 | $24,722 | 120 | GlaxoSmithKline, LLC. ($22,914) |
| 2019 | $21,198 | 235 | GlaxoSmithKline, LLC. ($17,620) |
| 2018 | $3,973 | 239 | Amgen Inc. ($765.18) |
| 2017 | $1,041 | 54 | Amgen Inc. ($403.33) |
All Payment Transactions
1,593 individual payment records from CMS Open Payments — Page 1 of 64
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| 12/16/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Travel and Lodging | Cash or cash equivalent | $77.05 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Travel and Lodging | Cash or cash equivalent | $179.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $16.21 | General |
| Category: Immunology | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 11/18/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $0.28 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Travel and Lodging | In-kind items and services | $1,223.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Travel and Lodging | In-kind items and services | $309.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $100.85 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $95.85 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 889 | 34,784 | $1.3M | $685,487 |
| 2022 | 20 | 1,085 | 31,509 | $1.2M | $714,701 |
| 2021 | 29 | 2,069 | 32,853 | $1.4M | $781,593 |
| 2020 | 29 | 2,427 | 27,690 | $1.4M | $862,058 |
Total Patients
6,470
Total Services
126,836
Medicare Billing
$3.0M
Procedure Codes
99
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 15 | 9,425 | $471,250 | $317,502 | 67.4% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 26 | 18,850 | $452,400 | $199,504 | 44.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 54 | 4,200 | $126,000 | $77,062 | 61.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 211 | 501 | $75,150 | $41,676 | 55.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 74 | 320 | $67,200 | $27,965 | 41.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 30 | 71 | $14,910 | $3,202 | 21.5% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 24 | 675 | $4,335 | $2,705 | 62.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 49 | $5,880 | $2,690 | 45.7% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 19 | 128 | $6,400 | $2,498 | 39.0% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 21 | 44 | $4,840 | $2,251 | 46.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $4,000 | $2,212 | 55.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 51 | 51 | $6,885 | $1,732 | 25.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 29 | 33 | $4,485 | $1,439 | 32.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 55 | 81 | $2,025 | $722.40 | 35.7% |
| 73120 | X-ray of hand, 2 views | Office | 2023 | 14 | 28 | $1,204 | $581.62 | 48.3% |
| 73620 | X-ray of foot, 2 views | Office | 2023 | 12 | 24 | $1,032 | $477.15 | 46.2% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 14 | 70 | $1,600 | $465.31 | 29.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 55 | 56 | $840.00 | $426.16 | 50.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 29 | 37 | $432.00 | $212.95 | 49.3% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 47 | 48 | $1,200 | $127.20 | 10.6% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 44 | 73 | $1,095 | $35.36 | 3.2% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 19 | 11,350 | $582,500 | $394,220 | 67.7% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2022 | 20 | 13,200 | $327,900 | $155,445 | 47.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 51 | 3,780 | $113,400 | $64,277 | 56.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 209 | 488 | $73,200 | $41,000 | 56.0% |
About Dr. Ryan Weldon, M.D
Dr. Ryan Weldon, M.D is a Internal Medicine healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1568724870.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Weldon, M.D has received a total of $380,099 in payments from pharmaceutical and medical device companies, with $81,924 received in 2024. These payments were reported across 1,593 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($283,160).
As a Medicare-enrolled provider, Weldon has provided services to 6,470 Medicare beneficiaries, totaling 126,836 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Birmingham, AL
- Active Since 06/12/2012
- Last Updated 09/29/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1568724870
Products in Payments
- BENLYSTA (Biological) $197,541
- SAPHNELO (Biological) $88,550
- KRYSTEXXA (Biological) $29,010
- OFEV (Drug) $11,959
- RINVOQ (Biological) $2,969
- Enbrel (Biological) $1,688
- XELJANZ (Drug) $1,466
- Cimzia (Drug) $1,356
- COSENTYX (Biological) $1,164
- ORENCIA (Biological) $948.47
- TREMFYA (Drug) $820.47
- SKYRIZI (Biological) $715.07
- Humira (Biological) $713.68
- TALTZ (Drug) $684.64
- ACTHAR (Biological) $655.84
- COSENTYX (Drug) $612.25
- Tymlos (Biological) $609.14
- EVENITY (Biological) $560.98
- Prolia (Biological) $504.66
- PURIFIED CORTROPHIN GEL (Drug) $360.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Birmingham
Rudolph Navari, M.d, M.D
Internal Medicine — Payments: $335,135
Internal Medicine $335,135
Dr. Robert Lewis, M.d, M.D
Internal Medicine — Payments: $176,028
Internal Medicine $176,028
Dr. James Sullivan, Md, MD
Internal Medicine — Payments: $146,354
Internal Medicine $146,354
Jose Vargas, M.d, M.D
Internal Medicine — Payments: $140,921
Internal Medicine $140,921
Dr. Jordan Vaughn, M.d, M.D
Internal Medicine — Payments: $90,874
Internal Medicine $90,874
David Deatkine, Md, MD
Internal Medicine — Payments: $83,978
Internal Medicine $83,978